66 results on '"Esposito MR"'
Search Results
2. Influenza vaccination and healthcare workers: barriers and predisposing factors
- Author
-
Guillari A, Polito F, Pucciarelli G, Serra N, Gargiulo G, Esposito MR, Botti S, Rea T, SIMEONE S, Guillari, A, Polito, F, Pucciarelli, G, Serra, N, Gargiulo, G, Esposito, Mr, Botti, S, Rea, T, and Simeone, S
- Abstract
Background and aim of the work: Influenza is a disease that affects a large part of the world's population annually, with major health, social and economic impacts. Active immunisation practices have always been recommended to counter influenza, especially for people at risk. The recommendations of major health agencies strongly advise influenza vaccination for all healthcare workers, mostly for those in contact with at-risk or immunocompromised individuals. Yet, the influenza vaccination coverage among healthcare workers remains rather low worldwide. This review explore barriers and the facilitators of health care professional toward influenza's vaccination. Methods: Narrative review consulting the databases: PubMed, CINAHL by combining keywords health care worker, flu, influenza, vaccination, barrier, resistence, hesitangy, between November 2019 and February 2020 Results. From the 1031 records initially, twenty-two primary studies were included in this narrative review. Our results show that the identified facilitators are: desire for self-protection, protection for loved ones and community. Instead, the barriers to vaccination identified are: fear of contracting influenza from the vaccination itself; not considering themselves at risk; to believing believe that their immune system is capable of managing a trivial disease; disease considered trivial, laziness; false beliefs. Discussion and conclusion: Adherence rate on influenza vaccination among health professionals is quite low. The interventions that make it "complex and traceable" flu vaccination refusal increase adherence to this type of vaccination. The results show that current vaccination campaigns do not increase the rate of adherence by healthcare workers. Identifying the predisposing factors and barriers to such vaccination can help to create, develop and test targeted educational programmes.
- Published
- 2021
3. Peer Review #1 of "Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma (v0.1)"
- Author
-
Esposito, MR, additional
- Published
- 2021
- Full Text
- View/download PDF
4. Cornell Assessment of Pediatric Delirium: an Italian Cultural Linguistic Validation and preliminary testing.Validazione Linguistico Culturale italiana e analisi preliminari della Cornell Assessment of Pediatric Delirium
- Author
-
Simeone S, Rea T, Gargiulo G, Esposito MR, Guillari A, Traube C, Silver G, Pucciarelli G., Simeone, S, Rea, T, Gargiulo, G, Esposito, Mr, Guillari, A, Traube, C, Silver, G, and Pucciarelli, G.
- Published
- 2019
5. Human Papillomavirus Infection and Vaccination: Knowledge and Attitudes among Nursing Students in Italy
- Author
-
Pelullo CP, Esposito MR, Di Giuseppe G., Pelullo, Cp, Esposito, Mr, and Di Giuseppe, G.
- Published
- 2019
6. CHEST TUBE REMOVAL: COMPARISON OF TWO PAIN MANAGEMENT IN PEDIATRIC CARDIAC SURGERY
- Author
-
simeone s, Platone N, Pucciarelli G, Assanta N, Perrone M, Sena G., Rea T, Guillari A, Esposito MR, Artiola G, Gargiulo G, Baratta S., Simeone, S, Platone, N, Pucciarelli, G, Assanta, N, Perrone, M, Sena, G., Rea, T, Guillari, A, Esposito, Mr, Artiola, G, Gargiulo, G, and Baratta, S.
- Abstract
Background and aim: Cardiac surgery requires the insertion of drainage into the pleural or mediastinal spaces. These drains are generally removed within 24 to 48 hours after surgery. Removal of the cardiac/thoracic drainage/tube (Chest Tube Removal: CTR) is associated with moderate to severe pain. During CTR, separating the thoracic tube from tissue causes pain in patients because,while the drainage isin place, the endothelium covering the thoracic cavity adheres to the tube. The tensile force of the tube removal can tear these adhesions and cause pain. Literature highlights how early removal can reduce the perception of the painful stimulus of this procedure. However, this is not always possible; indeed, in some cases a tube remains inside of a patient for several days and its removal may take place outside of intensive care, in the “general” ward. Pain from CTR can cause inadequate lung expansion; secretion retention due to ineffective cough; and immobility that promotes hypoxemia, atelectasis, and pneumonia. The use of analgesics is the most common method to relieve pain induced by CTR, but this maneuver is often performed without the use of analgesics drugs or other analgesic techniques. Furthermore,the use of specific analgesics outside of environments considered protected, such as intensive care, is still some what a taboo. A recent literature review emphasizes how current pain management protocols associated with CTR, using a variety of pharmacological and non-pharmacological techniques, are either non-existent or unsatisfactory. Yet the control of pain is a specific competence and requirementofour profession—even legally—for all ages. Through the use of validated tools, our study compares a new analgesic protocol (Group A: drugs Atropine mg/kg, Midazolam mg/kg, andKetamine mg/kg) versus Paracetamol mg/Kg (Group B), the drug mostly used as an pediatric analgesic. Methods: A multi-center comparative study. Results: During the period between January 9, 2018 and March 31, 2018, we observed 32 participants in two centers. The average age of participants was five and a half years. T-tests for dependent and independent samples were performed. In the standardized samples, pre- and post-CRT pain evalutations were performed. The pre-procedure evaluation between the two samples shows no statistically significant difference (p=0.154). At post-evaluation, the protocol GroupA showed a significant difference (p=0.001) compared to the protocol Group B. Conclusion: Preliminary results show a greater efficacy with protocol Group A compared to Paracetamol for the management of pain also outside of the pediatric intensive care unit, when CTR is actuated in a ward of pediatric cardiac surgery
- Published
- 2018
7. 332 - MONTE CARLO SIMULATIONS OF X-RAY SLOT-SCANNING PEDIATRIC AND ADULT EXAMINATIONS: COMPARISON WITH IN-PHANTOM THERMOLUMINESCENT DOSIMETRY
- Author
-
Piai, Mrs Anna, Loria, Mr Alessandro, Magnino, Mr Simone, Esposito, Mr Pier Giorgio, Campoleoni, Mr Mauro, Sconfienza, Luca Maria, and del Vecchio, Mrs Antonella
- Published
- 2022
- Full Text
- View/download PDF
8. Conoscenze e percezioni sull'utilizzo delle sostanze per l'aumento della performance: un survey negli utenti delle palestre
- Author
-
Enrico De Dominicis, Cammarano, A, Roberta, S, Esposito, Mr, Maurici, M, Marella, Gl, and Marsella, Lt
- Subjects
Settore MED/43 - Medicina Legale ,Settore MED/42 - Igiene Generale e Applicata - Published
- 2017
9. Second Generation Tyrosine Kinase Inhibitors (2G-TKI) in the Frontline Treatment of Elderly Patients with Chronic Myeloid Leukemia
- Author
-
Stagno, F, Latagliata, R, Annunziata, M, Abruzzese, E, Castagnetti, F, Iurlo, A, Bocchia, M, Crugnola, M, Sgherza, N, Guarini, A, Sora, F, Capodanno, I, Fava, C, Gozzini, A, Bonifacio, M, Leonetti, Sc, Galimberti, S, Feo, C, Montefusco, E, Tiribelli, M, Pregno, P, Bergamaschi, M, Rizzo, M, Antolino, A, Mauro, E, Rossi, Ar, Martino, B, Palmieri, R, Esposito, Mr, Iovine, M, Danise, P, Sica, A, Vigneri, P, Breccia, M, Rosti, G, Foa, R, and Luciano, L
- Published
- 2017
10. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
- Author
-
Lasorsa VA, Formicola D, Pignataro P, Cimmino F, Calabrese FM, Mora J, Esposito MR, Pantile M, Zanon C, De Mariano M, Longo L, Hogarty MD, de Torres C, Tonini GP, Iolascon A, and Capasso M
- Subjects
neuroblastoma ,NGS ,somatic mutation ,high risk ,cancer driver genes - Abstract
The spectrum of somatic mutation of the most aggressive forms of neuroblastoma is not completely determined. We sought to identify potential cancer drivers in clinically aggressive neuroblastoma.Whole exome sequencing was conducted on 17 germline and tumor DNA samples from high-risk patients with adverse events within 36 months from diagnosis (HR-Event3) to identify somatic mutations and deep targeted sequencing of 134 genes selected from the initial screening in additional 48 germline and tumor pairs (62.5% HR-Event3 and high-risk patients), 17 HR-Event3 tumors and 17 human-derived neuroblastoma cell lines.We revealed 22 significantly mutated genes, many of which implicated in cancer progression. Fifteen genes (68.2%) were highly expressed in neuroblastoma supporting their involvement in the disease. CHD9, a cancer driver gene, was the most significantly altered (4.0% of cases) after ALK.Other genes (PTK2, NAV3, NAV1, FZD1 and ATRX), expressed in neuroblastoma and involved in cell invasion and migration were mutated at frequency ranged from 4% to 2%.Focal adhesion and regulation of actin cytoskeleton pathways, were frequently disrupted (14.1% of cases) thus suggesting potential novel therapeutic strategies to prevent disease progression.Notably BARD1, CHEK2 and AXIN2 were enriched in rare, potentially pathogenic, germline variants.In summary, whole exome and deep targeted sequencing identified novel cancer genes of clinically aggressive neuroblastoma. Our analyses show pathway-level implications of infrequently mutated genes in leading neuroblastoma progression.
- Published
- 2016
11. CLINICAL OUTCOME OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH DELETION AND INSERTION EVENTS (DI) IN THE TYROSINE KINASE DOMAIN OF BCR-ABL
- Author
-
Peluso AL, Seneca E, Cosenza MR, Musella F, Cacciapuoti V, Esposito N, Muccioli Casadei G, Pisano I, De Angelis B, Annunziata M, Sessa U, Nunziata G, Palmieri F, Palmieri R, Danise P, Pezzullo L, Serio B, Esposito MR, Villa MR, Spiezia M, Vallone R, De Falco G, Sica A, Camera A, Iovine M, Svanera L, Soverini S, Martinelli G, Luciano L, QUINTARELLI, CONCETTA, IZZO, BARBARA, PANE, FABRIZIO, Peluso AL, Peluso, Al, Quintarelli, Concetta, Seneca, E, Cosenza, Mr, Musella, F, Cacciapuoti, V, Esposito, N, Izzo, Barbara, Muccioli Casadei, G, Pisano, I, De Angelis, B, Annunziata, M, Sessa, U, Nunziata, G, Palmieri, F, Palmieri, R, Danise, P, Pezzullo, L, Serio, B, Esposito, Mr, Villa, Mr, Spiezia, M, Vallone, R, De Falco, G, Sica, A, Camera, A, Iovine, M, Svanera, L, Soverini, S, Martinelli, G, Luciano, L, and Pane, Fabrizio
- Published
- 2013
12. Congenital dyserythropoietic anaemias: new acquisitions
- Author
-
IOLASCON, ACHILLE, RUSSO, ROBERTA, Esposito MR, Piscopo C, Asci R, De Falco L, Di Noce F., Iolascon, Achille, Russo, Roberta, Esposito, Mr, Piscopo, C, Asci, R, De Falco, L, and Di Noce, F.
- Published
- 2011
13. Management dell’infezione da HBV nel paziente oncoematologico in trattamento immunosoppressivo: la nostra esperienza
- Author
-
MARRONE, Aldo, Esposito MR, Marino R, Ciervo A, Villano A, Boemio A, D’Amore C, ZAMPINO, Rosa, Guerrera B, Cesaro F, Mastrullo L, Ruggiero G., Marrone, Aldo, Esposito, Mr, Marino, R, Ciervo, A, Villano, A, Boemio, A, D’Amore, C, Zampino, Rosa, Guerrera, B, Cesaro, F, Mastrullo, L, and Ruggiero, G.
- Published
- 2010
14. Efficacia e sicurezza dell’entecavir nel controllo dell’infezione da HBV nel paziente oncoematologico
- Author
-
MARRONE, Aldo, Esposito MR, Marino R, D’Amore C. Ciervo A, Villano A, Boemio A, Cesaro F, Ruggiero G, Mastrullo L., Marrone, Aldo, Esposito, Mr, Marino, R, D’Amore C., Ciervo A, Villano, A, Boemio, A, Cesaro, F, Ruggiero, G, and Mastrullo, L.
- Published
- 2010
15. Missense mutations in the ABVB6 transporter cause dominat familial pseudohyperkaliemia
- Author
-
Andolfo, I, Alper, Sl, Delaunay, J, Auriemma, C, Russo, R, Asci, R, Esposito, Mr, Sharma, Ak, Shmukler, Be, Brugnara, C, DE FRANCESCHI, Lucia, and Iolascon, A.
- Subjects
stomatocytosis ,ABCB6 mutations ,familial pseudohyperkaliemia - Published
- 2013
16. Salivary pH level and bacterial plaque evaluation in orthodontic patients treated with Recaldent® products
- Author
-
Marchisio, O, primary, Esposito, MR, additional, and Genovesi, A, additional
- Published
- 2010
- Full Text
- View/download PDF
17. Gli artigiani tra crisi e desiderio di sviluppo
- Author
-
Corradini S, Mancuso A, Primerano I, Prota L, Serino M, Acconcia A., Bianco R., Caroleo F.E., Corradini S., D’Esposito MR, Del Monte A,Esposito De Falco S, Guarino A, Morvillo A, Napolitano MR, Santoro G, Sarracino F, Verde R, Corradini, S, Mancuso, A, Primerano, I, Prota, L, and Serino, M
- Published
- 2019
18. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1
- Author
-
Maria D'Armiento, Lucia De Franceschi, Seth L. Alper, Boris E. Shmukler, Stanley L. Schrier, David H. Vandorpe, Annalisa Vetro, Maria Rosaria Esposito, Bertil Glader, Achille Iolascon, Orsetta Zuffardi, Jean Delaunay, Donatella Montanaro, Carla Auriemma, Gordon W. Stewart, Immacolata Andolfo, Ivan Limongelli, Roberta Russo, Carlo Brugnara, Luigia De Falco, Rupa Narayan, Fara Vallefuoco, Andolfo, I, Alper, Sl, De Franceschi, L, Auriemma, C, Russo, Roberta, De Falco, L, Vallefuoco, F, Esposito, Mr, Vandorpe, Dh, Shmukler, Be, Narayan, R, Montanaro, D, D'Armiento, Maria, Vetro, A, Limongelli, I, Zuffardi, O, Glader, Be, Schrier, Sl, Brugnara, C, Stewart, Gw, Delaunay, J, and Iolascon, Achille
- Subjects
Adult ,Hemolytic anemia ,Hydrops Fetalis ,Molecular Sequence Data ,Immunology ,Mice, Transgenic ,Anemia, Hemolytic, Congenital ,Transfection ,medicine.disease_cause ,Models, Biological ,Biochemistry ,Ion Channels ,Mice ,Xenopus laevis ,MISSENSE MUTATION ,medicine ,Animals ,Humans ,Missense mutation ,HEMOLYTIC ANEMIA ,Amino Acid Sequence ,Genetics ,Mutation ,Sequence Homology, Amino Acid ,business.industry ,PIEZO1 ,Gene Expression Regulation, Developmental ,Cell Biology ,Hematology ,Embryo, Mammalian ,medicine.disease ,Molecular biology ,Pedigree ,medicine.anatomical_structure ,stomatocytosis ,Dehydrated hereditary stomatocytosis ,Female ,Bone marrow ,business ,Cation transport ,Stomatocytosis - Abstract
Autosomal dominant dehydrated hereditary stomatocytosis (DHSt) usually presents as a compensated hemolytic anemia with macrocytosis and abnormally shaped red blood cells (RBCs). DHSt is part of a pleiotropic syndrome that may also exhibit pseudohyperkalemia and perinatal edema. We identified PIEZO1 as the disease gene for pleiotropic DHSt in a large kindred by exome sequencing analysis within the previously mapped 16q23-q24 interval. In 26 affected individuals among 7 multigenerational DHSt families with the pleiotropic syndrome, 11 heterozygous PIEZO1 missense mutations cosegregated with disease. PIEZO1 is expressed in the plasma membranes of RBCs and its messenger RNA, and protein levels increase during in vitro erythroid differentiation of CD34(+) cells. PIEZO1 is also expressed in liver and bone marrow during human and mouse development. We suggest for the first time a correlation between a PIEZO1 mutation and perinatal edema. DHSt patient red cells with the R2456H mutation exhibit increased ion-channel activity. Functional studies of PIEZO1 mutant R2488Q expressed in Xenopus oocytes demonstrated changes in ion-channel activity consistent with the altered cation content of DHSt patient red cells. Our findings provide direct evidence that R2456H and R2488Q mutations in PIEZO1 alter mechanosensitive channel regulation, leading to increased cation transport in erythroid cells.
- Published
- 2013
19. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II
- Author
-
Elizabeth Yang, Concetta Langella, Francesco Vitiello, Roberta Russo, Achille Iolascon, Fara Vallefuoco, Antonella Gambale, Torben Ek, Maria Rosaria Esposito, Russo, Roberta, Langella, C, Esposito, Mr, Gambale, A, Vitiello, F, Vallefuoco, F, Ek, T, Yang, E, and Iolascon, Achille
- Subjects
Adult ,Male ,CDA II ,Congenital dyserythropoietic anemia type II ,Genotype ,Nonsense mutation ,Vesicular Transport Proteins ,Biology ,Compound heterozygosity ,medicine.disease_cause ,Article ,Exon ,medicine ,Humans ,Amino Acid Sequence ,Child ,Molecular Biology ,Gene ,Anemia, Dyserythropoietic, Congenital ,Genetics ,Mutation ,Polymorphism, Genetic ,Base Sequence ,Genotype–phenotype correlation ,Hypomorphic mutations ,Cell Biology ,Hematology ,Exons ,medicine.disease ,Phenotype ,Introns ,Pedigree ,Molecular Medicine ,Female ,RNA Splice Sites ,SEC23B - Abstract
Congenital dyserythropoietic anemia type II, a recessive disorder of erythroid differentiation, is due to mutations in SEC23B, a component of the core trafficking machinery COPII. In no case homozygosity or compound heterozygosity for nonsense mutation(s) was found. This study represents the first description of molecular mechanisms underlying SEC23B hypomorphic genotypes by the analysis of five novel mutations. Our findings suggest that reduction of SEC23B gene expression is not associated with CDA II severe clinical presentation; conversely, the combination of a hypomorphic allele with one functionally altered results in more severe phenotypes. We propose a mechanism of compensation SEC23A-mediated which justifies these observations.
- Published
- 2013
20. A Dyserythropoietic Anemia Associated with Homozygous Hb Plasencia [α125(H8)Leu→Arg (α2)] (HBA2:c.377T>G), A Variant with an Unstable α Chain
- Author
-
Hermann Heimpel, Odile Fenneteau, Jean Delaunay, Achille Iolascon, Loïc Garçon, Madeleine Fénéant-Thibault, Roberta Russo, Maria Rosaria Esposito, Serge Pissard, Garçon, L, Iolascon, Achille, Pissard, S, Esposito, Mr, Russo, Roberta, Fenneteau, O, Fénéant Thibault, M, Heimpel, H, and Delaunay, J.
- Subjects
Adult ,Anemia ,Hemoglobins, Abnormal ,Thalassemia ,DNA Mutational Analysis ,Clinical Biochemistry ,Mutation, Missense ,Biology ,alpha-Globins ,hemic and lymphatic diseases ,medicine ,Humans ,Missense mutation ,Genetics (clinical) ,Anemia, Dyserythropoietic, Congenital ,Base Sequence ,Microcytosis ,Biochemistry (medical) ,Erythroid Hyperplasia ,Hematology ,medicine.disease ,anemia ,Molecular biology ,CDA ,Immunology ,Female ,Hemoglobin ,Congenital dyserythropoietic anemia ,dyserythropoiesi ,Dyserythropoietic anemia - Abstract
A female patient of Portuguese origin, who was born to consanguineous parents, presented with moderate anemia, mild jaundice and splenomegaly. Bone marrow aspiration showed an erythroid hyperplasia and binucleate erythroblasts, evoking a congenital dyserythropoietic anemia, type II (CDA II). Although microcytosis cast some doubt on the diagnosis, investigation was pursued along this line. The CDA II was finally ruled out as underglycosylation of band 3, remnants of endoplasmic reticulum cisternae and mutations in the SEC23B gene were all missing. On the other hand, analysis of the α-globin genes showed a base substitution at codon 125 (CTG→CGG) of the α2-globin gene, ascertaining a homozygosity for Hb Plasencia (HBA2:c.377T>G). This variant has an unstable α chain. In the absence of a thorough work-up, dyserythropoietic anemia associated with hemoglobin (Hb) variants having a moderately unstable α chain, may be mistaken for CDA II.
- Published
- 2010
21. Mutational spectrum in congenital dyserythropoietic anemia type II: Identification of 19 novel variants in SEC23B gene
- Author
-
Maria Rosaria Esposito, Roberta Asci, Gian Luca Forni, Vedat Uygun, Roberta Russo, Jean Delaunay, Silverio Perrotta, Achille Iolascon, Antonella Gambale, Ugo Ramenghi, Russo, Roberta, Esposito, Mr, Asci, R, Gambale, A, Perrotta, S, Ramenghi, U, Forni, Gl, Uygun, V, Delaunay, J, Iolascon, Achille, Russo, R, Perrotta, Silverio, and Iolascon, A.
- Subjects
Male ,Anemia ,Dyserythropoietic anemia ,Genotype ,Congenital dyserythropoietic anemia type II ,DNA Mutational Analysis ,Nonsense mutation ,Vesicular Transport Proteins ,Biology ,Compound heterozygosity ,medicine.disease_cause ,History, 21st Century ,Exon ,Gene Frequency ,Bone Marrow ,medicine ,Missense mutation ,Humans ,Family ,Erythropoiesis ,Registries ,Anemia, Dyserythropoietic, Congenital ,Genetics ,Mutation ,Computational Biology ,Genetic Variation ,Hematology ,History, 20th Century ,medicine.disease ,anemia ,dyserythropoiesis ,CDA ,Female ,Allelic heterogeneity ,Sequence Alignment ,eryhtropoiesi ,Research Article - Abstract
SEC23B gene encodes an essential component of the coat protein complex II (COPII)-coated vesicles. Mutations in this gene cause the vast majority the congenital dyserythropoietic anemia Type II (CDA II), a rare disorder resulting from impaired erythropoiesis. Here, we investigated 28 CDA II patients from 21 unrelated families enrolled in the CDA II International Registry. Overall, we found 19 novel variants [c.2270 A>C p.H757P; c.2149−2 A>G; c.1109+1 G>A; c.387(delG) p.L129LfsX26; c.1858 A>G p.M620V; c.1832 G>C p.R611P; c.1735 T>A p.Y579N; c.1254 T>G p.I418M; c.1015 C>T p.R339X; c.1603 C>T p.R535X; c.1654 C>T p.L552F; c.1307 C>T p.S436L; c.279+3 A>G; c. 2150(delC) p.A717VfsX7; c.1733 T>C p.L578P; c.1109+5 G>A; c.221+31 A>G; c.367 C>T p.R123X; c.1857_1859delCAT; p.I619del] in the homozygous or the compound heterozygous state. Homozygosity or compound heterozygosity for two nonsense mutations was never found. In four cases the sequencing analysis has failed to find two mutations. To discuss the putative functional consequences of missense mutations, computational analysis and sequence alignment were performed. Our data underscore the high allelic heterogeneity of CDA II, as the most of SEC23B variations are inherited as private mutations. In this mutation update, we also provided a tool to improve and facilitate the molecular diagnosis of CDA II by defining the frequency of mutations in each exon. Am. J. Hematol., 2010. © 2010 Wiley-Liss, Inc.
- Published
- 2010
22. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship
- Author
-
Silverio Perrotta, Jean Delaunay, Roberta Russo, Achille Iolascon, Roberta Asci, Madeleine Fénéant-Thibault, Loïc Garçon, Carmelo Piscopo, Maria Rosaria Esposito, Iolascon, Achille, Russo, Roberta, Esposito, Mr, Asci, R, Piscopo, C, Perrotta, S, Fénéant Thibault, M, Garçon, L, Delaunay, J., Iolascon, A, Russo, R, Perrotta, Silverio, and FÉNÉANT THIBAULT, M
- Subjects
Adult ,Genetic Markers ,Male ,Adolescent ,Genotype ,Congenital dyserythropoietic anemia type II ,Nonsense mutation ,Mutation, Missense ,Vesicular Transport Proteins ,Editorials and Perspectives ,Biology ,Compound heterozygosity ,medicine.disease_cause ,Cohort Studies ,Young Adult ,Gene Frequency ,medicine ,Humans ,Missense mutation ,Child ,Allele frequency ,Anemia, Dyserythropoietic, Congenital ,Genetics ,Mutation ,Infant, Newborn ,Infant ,Hematology ,Middle Aged ,medicine.disease ,Phenotype ,Codon, Nonsense ,Child, Preschool ,red cell ,Female ,Original Article ,Congenital dyserythropoietic anemia - Abstract
BACKGROUND: The most frequent form of congenital dyserythropoietic anemia is the type II form. Recently it was shown that the vast majority of patients with congenital dyserythropoietic anemia type II carry mutations in the SEC23B gene. Here we established the molecular basis of 42 cases of congenital dyserythropoietic anemia type II and attempted to define a genotype-phenotype relationship. DESIGN AND METHODS: SEC23B gene sequencing analysis was performed to assess the diversity and incidence of each mutation in 42 patients with congenital dyserythropoietic anemia type II (25 described exclusively in this work), from the Italian and the French Registries, and the relationship of these mutations with the clinical presentation. To this purpose, we divided the patients into two groups: (i) patients with two missense mutations and (ii) patients with one nonsense and one missense mutation. RESULTS: We found 22 mutations of uneven frequency, including seven novel mutations. Compound heterozygosity for a missense and a nonsense mutation tended to produce a more severe clinical presentation, a lower reticulocyte count, a higher serum ferritin level, and, in some cases, more pronounced transfusion needs, than homozygosity or compound heterozygosity for two missense mutations. Homozygosity or compound heterozygosity for two nonsense mutations was never found. CONCLUSIONS: This study allowed us to determine the most frequent mutations in patients with congenital dyserythropoietic anemia type II. Correlations between the mutations and various biological parameters suggested that the association of one missense mutation and one nonsense mutation was significantly more deleterious that the association of two missense mutations. However, there was an overlap between the two categories.
- Published
- 2009
23. Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population
- Author
-
Maria Luisa Serra, Hannah Tamary, Antonella Gambale, Roberta Russo, Mario Capasso, Achille Iolascon, Lucio Luzzatto, Ilaria De Maggio, Annaelena Troiano, Jean Delaunay, Maria Rosaria Esposito, Russo, Roberta, Gambale, A, Esposito, Mr, Serra, Ml, Troiano, A, De Maggio, I, Capasso, Mario, Luzzatto, L, Delaunay, J, Tamary, H, and Iolascon, Achille
- Subjects
Male ,Lineage (genetic) ,Congenital dyserythropoietic anemia type II ,DNA Mutational Analysis ,Vesicular Transport Proteins ,Biology ,medicine.disease_cause ,Polymorphism, Single Nucleotide ,Evolution, Molecular ,Gene Frequency ,medicine ,Prevalence ,Humans ,Registries ,Allele frequency ,Gene ,Genetic Association Studies ,Anemia, Dyserythropoietic, Congenital ,Genetics ,Mutation ,Mediterranean Region ,Haplotype ,Hematology ,medicine.disease ,Italian population ,Founder Effect ,Europe ,Amino Acid Substitution ,Haplotypes ,Italy ,Female ,Founder effect ,Research Article - Abstract
Congenital Dyserythropoietic Anemia type II is an autosomal recessive disorder characterized by unique abnormalities in the differentiation of cells of the erythroid lineage. The vast majority of CDA II cases result from mutations in the SEC23B gene. To date, 53 different causative mutations have been reported in 86 unrelated cases (from the CDA II European Registry), 47 of them Italian. We have now identified SEC23B mutations in 23 additional patients, 17 Italians and 6 non-Italian Europeans. The relative allelic frequency of the mutations was then reassessed in a total of 64 Italian and 45 non-Italian unrelated patients. Two mutations, E109K and R14W, account for over one-half of the cases of CDA II in Italy. Whereas the relative frequency of E109K is similar in Italy and in the rest of Europe (and is also prevalent in Moroccan Jews), the relative frequency of R14W is significantly higher in Italy (26.3% vs. 10.7%). By haplotype analysis we demonstrated that both are founder mutations in the Italian population. By using the DMLE+ program our estimate for the age of the E109K mutation in Italian population is ≈2,200 years; whereas for the R14W mutation it is ≈3,000 years. We hypothesize that E109K may have originated in the Middle East and may have spread in the heyday of the Roman Empire. Instead, R14W may have originated in Southern Italy. The relatively high frequency of the R14W mutation may account for the known increased prevalence of CDA II in Italy. Am. J. Hematol. 86:727–732, 2011. © 2011 Wiley-Liss, Inc.
- Published
- 2011
24. Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia
- Author
-
Roberta Asci, Carla Auriemma, Boris E. Shmukler, Carlo Brugnara, Jean Delaunay, Roberta Russo, Immacolata Andolfo, Seth L. Alper, Achille Iolascon, Maria Rosaria Esposito, Alok K. Sharma, Lucia De Franceschi, Andolfo, I, Alper, Sl, Delaunay, J, Auriemma, C, Russo, Roberta, Asci, R, Esposito, Mr, Sharma, Ak, Shmukler, Be, Brugnara, C, De Franceschi, L, and Iolascon, Achille
- Subjects
Adult ,Candidate gene ,Immunology ,Mutation, Missense ,medicine.disease_cause ,Biochemistry ,medicine ,Humans ,Missense mutation ,Familial pseudohyperkalemia ,Codon ,Gene ,Erythroid Precursor Cells ,Genetics ,Messenger RNA ,Mutation ,biology ,Red Cell ,ABCB6 ,Cell Biology ,Hematology ,Molecular biology ,Amino Acid Substitution ,Chromosomes, Human, Pair 2 ,Potassium ,biology.protein ,Hyperkalemia ,ATP-Binding Cassette Transporters ,Female ,K562 Cells ,Metabolism, Inborn Errors - Abstract
Abstract 3184 Isolated Familial Pseudohyperkalemia (FP) is a dominant red cell trait characterized by cold-induced slow ‘passive leak’ of red cell K+ into plasma, first described in a large Scottish family from Edinburgh (Stewart GW, et al., 1979). Although in freshly obtained blood samples plasma [K+] was normal, it was increased when measured in blood stored at or below room temperature. This trait was unaccompanied by clinical symptoms or signs except for mild abnormalities of red cell shape. FP Lille was later described in a large Flemish kindred with morphologically normal red cells (Dagher G, et al., 1989; Vantyghem MC, et al., 1991). In this family, red cell K+ efflux measured in the presence of ouabain and bumetanide was normal at 37°C, but greatly increased at 22°C and 9°C. FP Lille mapped to 2q35-q36 (Carella M, et al., 2004), whereas FP Edinburgh mapped to 16q23-qter (Iolascon A, et al., 1999). Subsequently, asymptomatic cases FP Chiswick and FP Falkirk with remarkable increased MCV were reported (Haines PG, et al., 2001). Functional gene mapping and sequencing analysis of the candidate genes within the 2q35-q36 critical interval in three multigenerational FP families with 20 affected individuals identified two novel heterozygous missense mutations in the ABCB6 gene that cosegregated with disease phenotype. The two genomic substitutions altered two adjacent nucleotides within codon 375 of ABCB6, a porphyrin transporter that in erythrocyte membranes bears the Langereis blood group antigen system (Krishnamurthy PC, et al., 2006; Helias V, et al., 2012). Structural modeling predicts subtle changes in protein structure associated with either mutation. ABCB6 mRNA and protein levels increased during erythroid differentiation of CD34+ erythroid precursors (at 7 and 14 days of EPO induced differentiation), and of HEL and K562 erythroleukemia cells. However, the ABCB6 R375Q mutation altered neither levels of ABCB6 mRNA or protein, nor protein localization in mature erythrocytes or erythroid precursor cells. These data strongly suggest that missense mutations in residue 375 of the ABCB6 polypeptide either mediate the cold-induced K+ leak of chromosome 2-linked FP, or activate an independent, cold-induced cation permeability pathway of the red cell. Disclosures: No relevant conflicts of interest to declare.
25. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: From morphology to molecular approach
- Author
-
Roberta Russo, Achille Iolascon, Maria Rosaria Esposito, Iolascon, Achille, Esposito, Mr, and Russo, Roberta
- Subjects
Genetics ,erythropoiesis anemia ,Endoplasmic reticulum ,Erythroid Hyperplasia ,Hematology ,Biology ,Golgi apparatus ,medicine.disease ,Pathogenesis ,symbols.namesake ,medicine.anatomical_structure ,Reticulocyte ,medicine ,symbols ,Animals ,Humans ,Erythropoiesis ,Bone marrow ,Congenital dyserythropoietic anemia ,Review Articles ,Anemia, Dyserythropoietic, Congenital - Abstract
Congenital dyserythropoietic anemias belong to a group of inherited conditions characterized by a maturation arrest during erythropoiesis with a reduced reticulocyte production in contrast with erythroid hyperplasia in bone marrow. The latter shows specific morphological abnormalities that allowed for a morphological classification of these conditions mainly represented by congenital dyserythropoietic anemias types I and II. The identification of their causative genes provided evidence that these conditions have different molecular mechanisms that induce abnormal cell maturation and division. Some altered proteins seem to be involved in the chromatin assembly, such as codanin-1 in congenital dyserythropoietic anemia I. The gene involved in congenital dyserythropoietic anemia II, the most frequent form, is SEC23B. This condition seems to belong to a group of diseases attributable to defects in the transport of newly synthesized proteins from endoplasmic reticulum to the Golgi. This review will analyze recent insights in congenital dyserythropoietic anemias types I and II. It will also attempt to clarify the relationship between mutations in causative genes and the clinical phenotype of these conditions.
26. Cytotoxic effects induced by combined exposure to the mycotoxins sterigmatocystin, ochratoxin A and patulin on human tumour and healthy 3D spheroids.
- Author
-
Zingales V, Esposito MR, Quagliata M, Cimetta E, and Ruiz MJ
- Subjects
- Humans, Cell Line, Tumor, Mesenchymal Stem Cells drug effects, Cell Survival drug effects, Neuroblastoma pathology, Ochratoxins toxicity, Patulin toxicity, Sterigmatocystin toxicity, Spheroids, Cellular drug effects
- Abstract
Humans are exposed to complex mixtures of mycotoxins through diet. Despite the serious threat they pose, mycotoxin risk assessment often overlooks co-exposure. With the aim of filling this gap, the present study investigates the combined cytotoxicity of sterigmatocystin (STE), ochratoxin A (OTA) and patulin (PAT) in human tumour Neuroblastoma and healthy Mesenchymal Stem Cells three-dimensional (3D) spheroids. The range of concentrations tested (1.56-50 μM for STE, 0.78-25 μM for OTA and 0.15-5 μM for PAT) was selected considering the IC
50 values obtained in previous studies and the estimated dietary exposure of consumers. To ensure appropriate experimental conditions, assessments for single mycotoxins and their combinations were conducted simultaneously. The nature of the toxicological interactions among the mycotoxins was then defined using the isobologram analysis. Our results demonstrated increased cytotoxicity in mycotoxin mixtures compared to individual exposure, with abundance of synergistic interactions. These findings highlight that the co-occurrence of STE, OTA and PAT in food may increase their individual toxic effects and should not be underestimated. Moreover, the use of advanced culture models increased the reliability and physiological relevance of our results which can serve as a groundwork for formulating standardized regulatory approaches towards mycotoxin mixtures in food and feed., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
27. Telehealth vs in-person education for enhancing self-care of ostomy patients (Self-Stoma): Protocol for a noninferiority, randomized, open-label, controlled trial.
- Author
-
Iovino P, Vellone E, Campoli A, Tufano C, Esposito MR, Guberti M, Bolgeo T, Sandroni C, Sili A, Manara DF, Alvaro R, Rasero L, and Villa G
- Subjects
- Humans, Quality of Life, Female, Male, Adult, Telemedicine, Self Care, Ostomy, Patient Education as Topic methods
- Abstract
Introduction: Postoperative patients with ostomies experience significant changes in their lives as a result of the device implantation. Self-care is important to improve their health outcomes. Telehealth provides an opportunity to expand access to self-care education., Aim: This is a multicenter, non-inferiority randomized, open-label, controlled trial to evaluate the non-inferiority of a telehealth intervention to the standard in-person approach in improving self-care behaviors., Methods and Analysis: Three hundred and eighty-four patients aged ≥ 18 years, with a recently placed ostomy, no stomal/peristomal complications, and documented cognitive integrity will be randomly assigned (1:1) to receive either a telehealth intervention (four remote educational sessions) or a standard educational approach (four in-person sessions) delivered in outpatient settings. Every session (remote and in-person) will occur on Days 25, 32, 40, and 60 after discharge. Follow-ups will occur 1, 3, and 6 months after the last intervention session. Primary outcome is self-care maintenance measured using the Ostomy Self-care Index (OSCI). Secondary outcomes include self-care monitoring, self-care management, self-efficacy (OSCI), quality of life (Stoma specific quality of Life), depression (Patient Health Questionnaire-9), adjustment (Ostomy Adjustment Inventory-23), stomal and peristomal complication rates, healthcare services utilization, mobility, and number of working days lost. Analyses will be performed per intention-to-treat and per protocol., Ethics and Dissemination: This study has been approved by the Institutional Review Board of the main center (registration number: 119/22). Following completion of the trial, dissemination meetings will be held to share the results of the study with the participants and the health-care team. Adoption of telehealth technologies for ostomy patients can improve service organization by ensuring better integration and continuity of care. If the remote intervention produces comparable effects to the in-person intervention, it would be wise to make telehealth education an alternative treatment for addressing the educational needs of uncomplicated postoperative ostomy patients., Trial Registration: ClinicalTrials.gov (identifier number: NCT05796544)., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Iovino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
28. Asymmetric Hydrogenation of Indazole-Containing Enamides Relevant to the Synthesis of Zavegepant Using Neutral and Cationic Cobalt Precatalysts.
- Author
-
Mendelsohn LN, MacNeil CS, Esposito MR, Pabst TP, Leahy DK, Davies IW, and Chirik PJ
- Abstract
The cobalt-catalyzed asymmetric hydrogenation of indazole-containing enamides relevant to the synthesis of the calcitonin gene-related peptide (CGRP) receptor antagonist, zavegepant ( 1 ), approved for the treatment of migraines, is described. Both neutral bis(phosphine)cobalt(II) and cationic bis(phosphine)cobalt(I) complexes served as efficient precatalysts for the enamide hydrogenation reactions, providing excellent yield and enantioselectivities (up to >99.9%) for a range of related substrates, though key reactivity differences were observed. Hydrogenation of indazole-containing enamide, methyl ( Z )-2-acetamido-3-(7-methyl-1 H -indazol-5-yl)acrylate, was performed on a 20 g scale.
- Published
- 2024
- Full Text
- View/download PDF
29. Comparative Study of Spheroids (3D) and Monolayer Cultures (2D) for the In Vitro Assessment of Cytotoxicity Induced by the Mycotoxins Sterigmatocystin, Ochratoxin A and Patulin.
- Author
-
Zingales V, Esposito MR, Quagliata M, Cimetta E, and Ruiz MJ
- Abstract
Mycotoxins are secondary metabolites produced by filamentous fungi associated with a variety of acute and chronic foodborne diseases. Current toxicology studies mainly rely on monolayer cell cultures and animal models, which are undeniably affected by several limitations. To bridge the gap between the current in vitro toxicology approach and the in vivo predictability of the data, we here investigated the cytotoxic effects induced by the mycotoxins sterigmatocystin (STE), ochratoxin A (OTA) and patulin (PAT) on different 2D and 3D cell cultures. We focused on human tumours (neuroblastoma SH-SY5Y cells and epithelial breast cancer MDA-MB-213 cells) and healthy cells (bone marrow-derived mesenchymal stem cells, BM-MSC, and umbilical vein endothelial cells, HUVECs). The cytotoxicity of STE, OTA, and PAT was determined after 24, 48 and 72 h of exposure using an ATP assay in both culture models. Three-dimensional spheroids' morphology was also analysed using the MATLAB-based open source software AnaSP 1.4 version. Our results highlight how each cell line and different culture models showed specific sensitivities, reinforcing the importance of using more complex models for toxicology studies and a multiple cell line approach for an improved and more comprehensive risk assessment.
- Published
- 2024
- Full Text
- View/download PDF
30. The Growing Importance of Three-Dimensional Models and Microphysiological Systems in the Assessment of Mycotoxin Toxicity.
- Author
-
Zingales V, Esposito MR, Torriero N, Taroncher M, Cimetta E, and Ruiz MJ
- Subjects
- Animals, Microphysiological Systems, Cell Culture Techniques methods
- Abstract
Current investigations in the field of toxicology mostly rely on 2D cell cultures and animal models. Although well-accepted, the traditional 2D cell-culture approach has evident drawbacks and is distant from the in vivo microenvironment. To overcome these limitations, increasing efforts have been made in the development of alternative models that can better recapitulate the in vivo architecture of tissues and organs. Even though the use of 3D cultures is gaining popularity, there are still open questions on their robustness and standardization. In this review, we discuss the current spheroid culture and organ-on-a-chip techniques as well as the main conceptual and technical considerations for the correct establishment of such models. For each system, the toxicological functional assays are then discussed, highlighting their major advantages, disadvantages, and limitations. Finally, a focus on the applications of 3D cell culture for mycotoxin toxicity assessments is provided. Given the known difficulties in defining the safety ranges of exposure for regulatory agency policies, we are confident that the application of alternative methods may greatly improve the overall risk assessment.
- Published
- 2023
- Full Text
- View/download PDF
31. Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
- Author
-
Luciano L, Latagliata R, Gugliotta G, Annunziata M, Tiribelli M, Martino B, Sica A, Esposito MR, Bocchia M, Galimberti S, Sorà F, Albano F, Palmieri R, Pregno P, Dragani M, Iovine M, Sica S, Iurlo A, Castagnetti F, Rosti G, and Breccia M
- Subjects
- Aged, Humans, Imatinib Mesylate therapeutic use, Pyrimidines adverse effects, Treatment Outcome, Protein Kinase Inhibitors adverse effects, Antineoplastic Agents adverse effects, Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
- Abstract
Here, we report real-world evidence on the safety and efficacy of nilotinib as a first-line treatment in elderly patients with chronic phase CML, treated in 18 Italian centers. Sixty patients aged > 65 years (median age 72 years (65-84)) were reported: 13 patients were older than 75 years. Comorbidities were recorded at baseline in 56/60 patients. At 3 months of treatment, all patients obtained complete hematological response (CHR), 43 (71.6%) an early molecular response (EMR), while 47 (78%) reached a complete cytogenetic response (CCyR). At last follow-up, 63.4% of patients still had a deep molecular response (MR4 or better), 21.6% reached MR3 as best response and 11.6% persisted without MR. Most patients (85%) started the treatment at the standard dose (300 mg BID), maintained at 3 months in 80% of patients and at 6 months in 89% of them. At the last median follow-up of 46.3 months, 15 patients discontinued definitively the treatment (8 due to side effects, 4 died for unrelated CML causes, 1 for failure, 2 were lost to follow-up). One patient entered in treatment-free remission. As to safety, 6 patients (10%) experienced cardiovascular events after a median time of 20.9 months from the start. Our data showed that nilotinib could be, as first-line treatment, effective and relatively safe even in elderly CML patients. In this setting, more data in the long term are needed about possible dose reduction to improve the tolerability, while maintaining the optimal molecular response., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
32. miR-210-3p enriched extracellular vesicles from hypoxic neuroblastoma cells stimulate migration and invasion of target cells.
- Author
-
Fusco P, Fietta A, Esposito MR, Zanella L, Micheli S, Bastianello A, Bova L, Borile G, Germano G, and Cimetta E
- Abstract
Background: Tumor hypoxia stimulates release of extracellular vesicles (EVs) that facilitate short- and long-range intercellular communication and metastatization. Albeit hypoxia and EVs release are known features of Neuroblastoma (NB), a metastasis-prone childhood malignancy of the sympathetic nervous system, whether hypoxic EVs can facilitate NB dissemination is unclear., Methods: Here we isolated and characterized EVs from normoxic and hypoxic NB cell culture supernatants and performed microRNA (miRNA) cargo analysis to identify key mediators of EVs biological effects. We then validated if EVs promote pro-metastatic features both in vitro and in an in vivo zebrafish model., Results: EVs from NB cells cultured at different oxygen tensions did not differ for type and abundance of surface markers nor for biophysical properties. However, EVs derived from hypoxic NB cells (hEVs) were more potent than their normoxic counterpart in inducing NB cells migration and colony formation. miR-210-3p was the most abundant miRNA in the cargo of hEVs; mechanistically, overexpression of miR-210-3p in normoxic EVs conferred them pro-metastatic features, whereas miR-210-3p silencing suppressed the metastatic ability of hypoxic EVs both in vitro and in vivo., Conclusion: Our data identify a role for hypoxic EVs and their miR-210-3p cargo enrichment in the cellular and microenvironmental changes favoring NB dissemination., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
33. Development of an in vitro neuroblastoma 3D model and its application for sterigmatocystin-induced cytotoxicity testing.
- Author
-
Zingales V, Torriero N, Zanella L, Fernández-Franzón M, Ruiz MJ, Esposito MR, and Cimetta E
- Subjects
- Blotting, Western, Cell Line, Tumor cytology, Cell Line, Tumor drug effects, Cell Movement drug effects, Comet Assay methods, Fluorescent Antibody Technique, Humans, Neuroblastoma, Reactive Oxygen Species metabolism, Spheroids, Cellular drug effects, Cell Culture Techniques, Three Dimensional methods, Mycotoxins toxicity, Sterigmatocystin toxicity, Toxicity Tests methods
- Abstract
Given the increasing importance of establishing better risk assessments for mycotoxins, novel in vitro tools for the evaluation of their toxicity are mandatory. In this study, an in vitro 3D spheroid model from SH-SY5Y cells, a human neuroblastoma cell line, was developed, optimized and characterized to test the cytotoxic effects caused by the mycotoxin sterigmatocystin (STE). STE induced a concentration- and time-dependent cell viability decrease in spheroids. Spheroids displayed cell disaggregation after STE exposure, increasing in a dose-dependent manner and over time. STE also induced apoptosis as confirmed by immunofluorescence staining and Western blot. Following the decreased proliferation and increased apoptosis, STE cytostasis effects were observed by migration assays both in 2D and 3D cell culture. Increased ROS generation, as well as DNA damage were also observed. Taken together, these data highlight the cytotoxic properties of STE and suggest that cell culture models play a pivotal role in the toxicological risk assessment of mycotoxins. The evaluation of cytotoxicity in spheroids (3D) rather than monolayer cultures (2D) is expected to more accurately reflect in vivo-like cell behaviour., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
34. Evaluation of soft skills among Italian Healthcare Rehabilitators: A cross sectional study.
- Author
-
Continisio GI, Serra N, Guillari A, Lucchese R, Simeone S, Gargiulo G, Toscano S, Capo M, Capuano A, Sarracino F, Esposito MR, and Rea T
- Abstract
Background: Healthcare rehabilitator skills can be grouped into hard and soft skills. Hard skills are specific and teachable, which can be defined and measured, while soft skills are less tangible and more difficult to quantify. The aim of this study is to investigate the level of knowledge of soft skills among Italian healthcare rehabilitators, and how they were acquired., Design and Methods: Two hundred healthcare rehabilitators, who worked in Southern Italy were enrolled from September 1st to October 31st 2017, and interviewed with Computer-Assisted-Web-Interview (CAWI) software, to assess their level of soft skills., Results: Healthcare rehabilitators showed significant satisfaction with university education (59.5%), particularly for theoretical training (64%), while significant dissatisfaction was found for technical-practical training (63.5%), training in patients' family management (66.5%) and stages participation to improve soft skills (59%). Dissatisfied rehabilitators were found for university education of soft skills (59%), particularly for interpersonal relationships with patients family (66.5%) and technical-practical train in(63.5%). Women considered the training courses about soft skills acquisition more useful than men (43.8%)., Conclusions: Healthcare rehabilitator training is lacking in the teaching of both technical-practical and soft skills. It is striking that in a healthcare profession like that of the rehabilitator, where practical and empathic skills are fundamental in the relationship with the patients, such skills are not treated in analogously with theoretical training.
- Published
- 2021
- Full Text
- View/download PDF
35. Verteporfin induces apoptosis and reduces the stem cell-like properties in Neuroblastoma tumour-initiating cells through inhibition of the YAP/TAZ pathway.
- Author
-
Fusco P, Mattiuzzo E, Frasson C, Viola G, Cimetta E, Esposito MR, and Tonini GP
- Subjects
- Cell Line, Tumor, Cell Movement drug effects, Cell Proliferation drug effects, Cisplatin pharmacology, Drug Repositioning, Etoposide pharmacology, Humans, Neoplasm Invasiveness, Neoplastic Stem Cells metabolism, Neoplastic Stem Cells pathology, Neuroblastoma metabolism, Neuroblastoma pathology, Side-Population Cells metabolism, Side-Population Cells pathology, Signal Transduction, Transcriptional Coactivator with PDZ-Binding Motif Proteins, YAP-Signaling Proteins, Adaptor Proteins, Signal Transducing metabolism, Antineoplastic Combined Chemotherapy Protocols pharmacology, Apoptosis drug effects, Neoplastic Stem Cells drug effects, Neuroblastoma drug therapy, Side-Population Cells drug effects, Trans-Activators metabolism, Transcription Factors metabolism, Verteporfin pharmacology
- Abstract
Neuroblastoma is an embryonal malignancy of early childhood arising from the embryonic sympatho-adrenal lineage of the neural crest. About half of all cases are currently classified as high-risk of disease recurrence, with an overall survival rate of less than 40% at 5 years despite intensive therapy. Recent studies on matched primary tumours and at the relapse revealed downregulation of genes transcriptionally silenced by YAP as significant association with neuroblastoma relapse. Here, we evaluated the pharmacological targeting of YAP/TAZ with the YAP/TAZ-TEAD inhibitor Verteporfin (VP) in Tumour Initiating Cells (TICs) derived from High-Risk Neuroblastoma patients. VP treatment suppresses YAP/TAZ expression, induces apoptosis and causes the re-organization of the cytoskeleton reducing cells migration and clonogenic ability. Moreover, VP reduces the percentage of side population cells and ABC transporters involved in drug resistance, and the percentage of stem cell subpopulations CD133+ and CD44
+ of TICs. Finally, we demonstrated that VP sensitizes TICs to the standard drugs used for neuroblastoma therapy etoposide and cis-platin opening the way to use VP as drug repositioning candidate for recurrent neuroblastoma., (Copyright © 2020 Elsevier B.V. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
36. A Psychometric Validation of the Decisional Conflict Scale in Italian Cancer Patients Scheduled for Insertion of Central Venous Access Devices.
- Author
-
Esposito MR, Guillari A, Giancamilli F, Rea T, Piredda M, DE Marinis MG, and Chirico A
- Subjects
- Adult, Aged, Aged, 80 and over, Central Venous Catheters adverse effects, Emotions, Female, Humans, Italy epidemiology, Male, Middle Aged, Neoplasms epidemiology, Neoplasms pathology, Neoplasms therapy, Surveys and Questionnaires, Uncertainty, Decision Making, Neoplasms psychology, Psychometrics
- Abstract
Background/aim: In oncological settings, high-quality decision-making takes place when an adaptive pattern of cognitive and behavioural processes occurs, potentially limiting post-decisional regret and leading to an increment of adherence to the final decision. An example of a choice that requires a patient's involvement in the decision-making during cancer treatment occurs when the insertion of Central Vascular Access Device (CVAD) is proposed for chemotherapy administration. The aim of the current study was to develop and evaluate the psychometric properties of an Italian version of the Decisional Conflict Scale (DCS), including its factorial structure and its accuracy in discriminating the level of uncertainty in a sample of cancer patients during their decision-making process for the insertion of a CVAD for intravenous (IV) chemotherapy administration., Materials and Methods: The study included 264 cancer patients with different diagnoses. To test the structural and psychometric properties of the Italian version of the DCS (DCS-ITA), exploratory factorial analysis was conducted followed by traditional classical test theory assessments of internal reliability and criterion validity., Results: The Italian version of the DCS (DCS-ITA) demonstrated good internal consistency, acceptable construct validity, which was tested with exploratory factorial analysis, and good criterion validity, demonstrated by the ability of the scale to differentiate between patients who declared themselves certain about their choice and patients expressing uncertainty about the choice to make., Conclusion: Overall, the results of the study showed that the DCS-ITA is a psychometrically sound instrument that easily discriminates between patients who are experiencing a decisional conflict and those who are not. The DCS-ITA can be used as a valid and easy-to-use tool for the screening of the decisional conflict in oncological settings., (Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
37. An investigation into Video Game Addiction in Pre-Adolescents and Adolescents: A Cross-Sectional Study.
- Author
-
Esposito MR, Serra N, Guillari A, Simeone S, Sarracino F, Continisio GI, and Rea T
- Subjects
- Adolescent, Behavior, Addictive epidemiology, Behavior, Addictive psychology, Child, Cross-Sectional Studies, Female, Humans, Italy epidemiology, Male, Surveys and Questionnaires, Video Games adverse effects, Behavior, Addictive diagnosis, Video Games psychology
- Abstract
Background and Objectives: Game addiction is an emerging problem in public health. A gaming disorder is characterized by a pattern of persistent or recurrent gaming behavior. The behavioral pattern is severe enough to implicate a significant involvement of family, social, educational, professional, or other relationships. Therefore, greater attention needs to be paid to potential addictive behaviors in terms of video games in order to identify both pre-adolescents and adolescents at risk and to provide them with adequate assistance. Materials and Methods : A random sample of 622 students including pre-adolescents and adolescents were enrolled from September 1st to October 31th 2016, and the Game Addiction Scale (GAS) interview was used to identify pathological students with both Monothetic and Polythetic analysis., Results: This study shows the presence of pathological students is equal to 1.93%, with 37.46% and 4.50% obtained with Monothetic and Polythetic analysis (global and partial), respectively. In our sample, the most frequent were students with a gaming time of 1 or 2 h, and students with a day gaming frequency of 1, 2, or 3 times a day. The items with more pathological students were Item 2 (i.e., Tolerance) and 4 (i.e., Withdrawal). Every item was positively correlated with Daily gaming time(hours) and Daily game frequency, excluding Item 4(i.e., Withdrawal). Finally, the Monothetic GAS score was positively correlated with Daily gaming time while the Polythetic Global GAS was positively correlated with Daily game frequency and negatively with Education level; instead, the Polythetic Partial GAS score was positively correlated with only Daily gaming time., Conclusion: Males are pathological gamblers more so than females and spend more time playing video games. An increase in Daily game frequency or Daily gaming time implicates an increase in video game addictions, while an increase in Education level, which generally corresponds to a greater age, implicates a decrease in game addiction. Finally, we observed that the correlations obtained between the Polythetic Partial GAS score with the independent variables such as Age, Gender, Education level, Daily gaming time (hours), and Daily game frequency were analogous to the significant correlations obtained with the Monothetic GAS score, while these correlations were different for the Polythetic Global GAS and the independent variables. These results suggest that the use of the original Polythetic scale should not be neglected., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2020
- Full Text
- View/download PDF
38. An investigation on parenting stress of children with cystic fibrosis.
- Author
-
Continisio GI, Serra N, Guillari A, Civitella MT, Sepe A, Simeone S, Gargiulo G, Toscano S, Esposito MR, Raia V, and Rea T
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Cystic Fibrosis complications, Cystic Fibrosis therapy, Female, Humans, Infant, Italy, Male, Middle Aged, Sex Factors, Socioeconomic Factors, Stress, Psychological diagnosis, Young Adult, Cystic Fibrosis psychology, Parenting psychology, Parents psychology, Stress, Psychological epidemiology
- Abstract
Background: The management of chronic diseases, particularly in children, requires an integrated physical and psychological approach to both sick children and their family. This is the case of Cystic Fibrosis (CF), a complex genetic chronic disease, where, a comprehensive evaluation of the emotional impact and an effective multidimensional approach are indicated., Aim: This study investigates on parenting stress in children and adolescents with CF and its determinants related to parents, children and the disease severity., Methods: The study involved 34.04% adult males and 65.96% adult females (range 21-55 years) and 47 children with CF, 54.35% males and 45.65% females (range 1-17 years). The data were obtained through a Parenting Stress Index - Short Form (PSI-SF) questionnaire. According to the PSI-SF scoring system, three types of stress were detected: a typical stress pattern (normal), a high stress pattern (increased) and a defensive response, which may be considered as a high stress feature in children which requires monitoring and clinical evaluation., Results: This study shows a significant presence of stress in females (60.23%), of subject married (84.62%), unemployed (69.23%) and with education level such as "middle School" (61.54%). Concerning children of parents with high stress, it resulted most frequent children with one sibling (53.85%). Finally, by univariate analysis, it resulted a significant positive correlation between parenting stress and disease degree of children. Instead by multivariate analysis, we found that the variables: Number of siblings and Birth order were a significant positive and negative predictor of parenting stress respectively., Conclusion: An increased stress level was detected in less than one third of parents of subjects with CF. These data may be related to the psychological support which is part of the routine management of CF care team. However, as children's features seem to act as a determinant of stress more than parental ones, the parental-child dysfunction should be the target for further integrated interventions.
- Published
- 2020
- Full Text
- View/download PDF
39. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.
- Author
-
Fusco P, Parisatto B, Rampazzo E, Persano L, Frasson C, Di Meglio A, Leslz A, Santoro L, Cafferata B, Zin A, Cimetta E, Basso G, Esposito MR, and Tonini GP
- Subjects
- Autonomic Nervous System Diseases metabolism, Biomarkers, Tumor metabolism, Biopsy, Child, Child, Preschool, Chromogranin A metabolism, Chromosome Aberrations, Gene Amplification genetics, Humans, Infant, N-Myc Proto-Oncogene Protein genetics, Neuroblastoma metabolism, Organoids metabolism, Receptors, G-Protein-Coupled metabolism, Synaptophysin metabolism, Autonomic Nervous System Diseases genetics, Autonomic Nervous System Diseases pathology, Models, Biological, Neuroblastoma genetics, Neuroblastoma pathology, Organoids pathology
- Abstract
Background: Neuroblastoma (NB) is a paediatric tumour of the sympathetic nervous system. Half of all cases are defined high-risk with an overall survival less than 40% at 5 years from diagnosis. The lack of in vitro models able to recapitulate the intrinsic heterogeneity of primary NB tumours has hindered progress in understanding disease pathogenesis and therapy response., Methods: Here we describe the establishment of 6 patient-derived organoids (PDOs) from cells of NB tumour biopsies capable of self-organising in a structure resembling the tissue of origin., Results: PDOs recapitulate the histological architecture typical of the NB tumour. Moreover, PDOs expressed NB specific markers such as neural cell adhesion molecules, NB84 antigen, synaptophysin (SYP), chromogranin A (CHGA) and neural cell adhesion molecule NCAM (CD56). Analyses of whole genome genotyping array revealed that PDOs maintained patient-specific chromosomal aberrations such as MYCN amplification, deletion of 1p and gain of chromosome 17q. Furthermore, the PDOs showed stemness features and retained cellular heterogeneity reflecting the high heterogeneity of NB tumours., Conclusions: We were able to create a novel preclinical model for NB exhibiting self-renewal property and allowing to obtain a reservoir of NB patients' biological material useful for the study of NB molecular pathogenesis and to test drugs for personalised treatments.
- Published
- 2019
- Full Text
- View/download PDF
40. The CiTAS scale for evaluating taste alteration induced by chemotherapy: state of the art on its clinical use.
- Author
-
Simeone S, Esposito MR, Gargiulo G, Lanzuise A, Botti S, Serra N, Continisio GI, Rea T, and Guillari A
- Subjects
- Humans, Neoplasms drug therapy, Neoplasms psychology, Quality of Life, Taste Disorders diagnosis, Antineoplastic Agents adverse effects, Taste Disorders chemically induced
- Abstract
Background: Cancer is the leading cause of death worldwide. Of the various therapeutic approaches, chemotherapy is the most widely used treatment. Among the various side effects associated with this treatment, taste alterations (TAs) have received little attention, even though they have a serious impact on the nutritional aspect and quality of life (QoL) of patients. TAs concern 75% of the patients receiving chemotherapy, and this figure is still considered to be underestimatedbeacuse could be due both to inadequate attention and to the absence of specific subjective tools able to fully evaluate TAs in patients undergoing chemotherapy., Methods: A review by querying CINAHL, PubMed, Scopus and Google Scholar databases about the current status of use of the CiTAS self-evaluation scale, was performed., Results: From critical reading of the selected reports, it can be said that until now CiTAS has not been used to a large extent for evaluating taste, even at a late stage in patients undergoing chemotherapy. However, the results and the selected reports seem to indicate hope for its wider use., Conclusions: In literature, CITAS scale has been used on very heterogeneous populations and not adequately studied in specific care settings, its use within controlled trials could implement its spread.Correct and subjective evaluation of TAs would allow the planning of specific and personalized interventions aimed at providing adequate nutrition to support the maintenance and/or achievement of a correct body mass index. All this could contribute significantly to a better perception of QoL in patients undergoing chemotherapy.
- Published
- 2019
- Full Text
- View/download PDF
41. Cornell Assessment of Pediatric Delirium: Italian cultural validation and preliminary testing.
- Author
-
Simeone S, Rea T, Gargiulo G, Esposito MR, Guillari A, Traube C, Silver GH, and Pucciarelli G
- Subjects
- Child, Preschool, Cross-Sectional Studies, Cultural Characteristics, Female, Humans, Infant, Intensive Care Units, Pediatric, Length of Stay, Male, Surveys and Questionnaires, Translations, Delirium diagnosis, Nursing Diagnosis methods
- Abstract
Introduction: Paediatric delirium is associated with a longer duration of hospitalization in paediatric intensive care units, the emergence of post-traumatic symptoms and possible neurocognitive dysfunction after discharge. In preschool children, the diagnosis of delirium appears rather challenging: their pre-verbal status and the presence of cognitive skills still in development make accurate diagnosis difficult. Recently, a pediatric delirium screening tool suitable for critical preschool children has also been developed and identified in international literature, with excellent results also in critical infants under 2 years of age: the Cornell Assessment of Pediatric Delirium (CAPD). The CAPD, using a Likert scale, bases the assessment of paediatric delirium within the context of child development. This scale follows the development of the infant by comparing the detection of specific items on the scale as the anchor points that characterize the development of infants by age groups., Objective: Culturally and linguistically validation in Italian language and prior testing of the Cornell Assessment of Pediatric Delirium., Method: Translation and Cultural Validation of the Cornell Assessment of Pediatric Delirium (CAPD) for the Evaluation/Diagnosis of Pediatric Delirium within Pediatric Intensive Care. The translation and adaptation of this instrument followed the phases of the model proposed by the World Health Organization. Prior testings, such as item descriptive analysis, item-total correlation and Cronbach's alpha, were conducted., Results: All phases of the cultural-linguistic validation process were carried out in a satisfactory manner. For the prior testing, the scale was administered to a sample of 42 children, with age ranged 0-5 years old (66.6%), with a higher prevalence of the male gender. All items were normally distributed and there was no excessive Skeweness and Kurtosis. Each item contributed to the scale fairly well and all coefficients of item total correlation (rjx) were higher than the recommended level of 0.30. The composite reliability index was 0.94 and Cronbach's alpha was 0.96., Conclusions: The process has meticulously followed the recommendations in international literature. The final version was approved by the authors of the original instrument.
- Published
- 2019
- Full Text
- View/download PDF
42. Chromosome instability in neuroblastoma.
- Author
-
Fusco P, Esposito MR, and Tonini GP
- Abstract
Neuroblastoma is a neural crest-derived tumor that accounts for 7-10% of all malignancies in children and ~15% of all childhood cancer-associated mortalities. Approximately 50% of patients are characterized as high-risk (HR) and have an overall survival of <40% at 5 years from diagnosis. HR patients with unfavorable prognosis exhibit several structural copy number variations (CNVs), whereas localized tumors belonging to patients in the low- and intermediate-risk classes, have favorable outcomes and display several numerical CNVs. Taken together these results are indicative of chromosome instability (CIN) in neuroblastoma tumor cells. The present review discusses multiple aspects of CIN including methods of measuring CIN, CIN targeting as a therapeutic strategy in cancer and the effects of CIN in neuroblastoma development and aggressiveness with particular emphasis on the CIN gene signature associated with HR neuroblastoma patients.
- Published
- 2018
- Full Text
- View/download PDF
43. Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.
- Author
-
Esposito MR, Binatti A, Pantile M, Coppe A, Mazzocco K, Longo L, Capasso M, Lasorsa VA, Luksch R, Bortoluzzi S, and Tonini GP
- Subjects
- Adolescent, Child, Child, Preschool, Cohort Studies, Female, Gene Regulatory Networks, Humans, Infant, MAP Kinase Signaling System, Male, Mutation, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Neuroblastoma metabolism, Survival Rate, Neuroblastoma genetics, Neuroblastoma mortality
- Abstract
Neuroblastoma (NB) is an embryonic malignancy of the sympathetic nervous system with heterogeneous biological, morphological, genetic and clinical characteristics. Although genomic studies revealed the specific biological features of NB pathogenesis useful for new therapeutic approaches, the improvement of high-risk (HR)-NB patients overall survival remains unsatisfactory. To further clarify the biological basis of disease aggressiveness, we used whole-exome sequencing to examine the genomic landscape of HR-NB patients at stage M with short survival (SS) and long survival (LS). Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor. A systems biology approach revealed that in the two patient groups, mutations occurred in different pathways. Mutated genes (ARHGEF11, CACNA1G, FGF4, PTPRA, PTK2, ANK3, SMO, NTNG2, VCL and NID2) regulate the MAPK pathway associated with the organization of the extracellular matrix, cell motility through PTK2 signaling and matrix metalloproteinase activity. Moreover, we detected mutations in LAMA2, PTK2, LAMA4, and MMP14 genes, impairing MET signaling, in SFI1 and CHD2 involved in centrosome maturation and chromosome remodeling, in AK7 and SPTLC2, which regulate the metabolism of nucleotides and lipoproteins, and in NALCN, SLC12A1, SLC9A9, which are involved in the transport of small molecules. Notably, connected networks of somatically mutated genes specific for SS patients were identified. The detection of mutated genes present at the onset of disease may help to address an early treatment of HR-NB patients using FDA-approved compounds targeting the deregulated pathways., (© 2018 UICC.)
- Published
- 2018
- Full Text
- View/download PDF
44. [Effectiveness of the Situation-Background-Assessment-Recommendation (SBAR) methodology in patient handovers between nurses, Italy].
- Author
-
Rea T, Simeone S, Annunziata M, Serio C, Esposito MR, Gargiulo G, and Guillari A
- Subjects
- Humans, Italy, Patient Care Team standards, Communication, Continuity of Patient Care standards, Patient Handoff standards
- Abstract
Exchange of information between healthcare professionals involved in the care of patients is essential for providing effective care. Use of the Situation-BackgroundAssessment-Recommendation (SBAR) methodology is increasingly indicated in the health sector to facilitate communication during handovers of patients between clinicians or clinical teams. The present review of the literature aims to determine the effectiveness of the SBAR methodology in the handover of nursing documentation.
- Published
- 2018
45. Knowledge, attitudes, and practice on the prevention of central line-associated bloodstream infections among nurses in oncological care: A cross-sectional study in an area of southern Italy.
- Author
-
Esposito MR, Guillari A, and Angelillo IF
- Subjects
- Adult, Catheter-Related Infections nursing, Cross-Sectional Studies, Female, Humans, Italy, Male, Middle Aged, Catheter-Related Infections prevention & control, Health Knowledge, Attitudes, Practice, Nursing Staff, Hospital
- Abstract
The objectives of the cross-sectional study were to delineate the knowledge, attitudes, and behavior among nurses regarding the prevention of central line-associated bloodstream infections (CLABSIs) and to identify their predisposing factors. A questionnaire was self-administered from September to November 2011 to nurses in oncology and outpatient chemotherapy units in 16 teaching and non-teaching public and private hospitals in the Campania region (Italy). The questionnaire gathered information on demographic and occupational characteristics; knowledge about evidence-based practices for the prevention of CLABSIs; attitudes towards guidelines, the risk of transmitting infections, and hand-washing when using central venous catheter (CVC); practices about catheter site care; and sources of information. The vast majority of the 335 nurses answered questions correctly about the main recommendations to prevent CLABSIs (use sterile gauze or sterile transparent semipermeable dressing to cover the catheter site, disinfect the needleless connectors before administer medication or fluid, disinfect with hydrogen peroxide the catheter insertion site, and use routinely anticoagulants solutions). Nurses aged 36 to 50 years were less likely to know these main recommendations to prevent CLABSIs, whereas this knowledge was higher in those who have received information about the prevention of these infections from courses. Nurses with lower education and those who do not know two of the main recommendations on the site's care to prevent the CLABSIs, were more likely to perceive the risk of transmitting an infection. Higher education, attitude toward the utility allow to dry antiseptic, and the need of washing hands before wearing gloves for access to port infusion were predictors of performing skin antiseptic and aseptic technique for dressing the catheter insertion site. Educational interventions should be implemented to address the gaps regarding knowledge and practice regarding the prevention of CLABSIs and to ensure that nurses use evidence-based prevention interventions.
- Published
- 2017
- Full Text
- View/download PDF
46. Neuroblastoma treatment in the post-genomic era.
- Author
-
Esposito MR, Aveic S, Seydel A, and Tonini GP
- Subjects
- Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Crizotinib, Humans, Antineoplastic Agents therapeutic use, Drug Delivery Systems methods, Drug Resistance, Neoplasm drug effects, Drug Resistance, Neoplasm genetics, Genomics, Neoplasm Proteins antagonists & inhibitors, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Neuroblastoma drug therapy, Neuroblastoma genetics, Neuroblastoma metabolism, Pyrazoles therapeutic use, Pyridines therapeutic use
- Abstract
Neuroblastoma is an embryonic malignancy of early childhood originating from neural crest cells and showing heterogeneous biological, morphological, genetic and clinical characteristics. The correct stratification of neuroblastoma patients within risk groups (low, intermediate, high and ultra-high) is critical for the adequate treatment of the patients.High-throughput technologies in the Omics disciplines are leading to significant insights into the molecular pathogenesis of neuroblastoma. Nonetheless, further study of Omics data is necessary to better characterise neuroblastoma tumour biology. In the present review, we report an update of compounds that are used in preclinical tests and/or in Phase I-II trials for neuroblastoma. Furthermore, we recapitulate a number of compounds targeting proteins associated to neuroblastoma: MYCN (direct and indirect inhibitors) and downstream targets, Trk, ALK and its downstream signalling pathways. In particular, for the latter, given the frequency of ALK gene deregulation in neuroblastoma patients, we discuss on second-generation ALK inhibitors in preclinical or clinical phases developed for the treatment of neuroblastoma patients resistant to crizotinib.We summarise how Omics drive clinical trials for neuroblastoma treatment and how much the research of biological targets is useful for personalised medicine. Finally, we give an overview of the most recent druggable targets selected by Omics investigation and discuss how the Omics results can provide us additional advantages for overcoming tumour drug resistance.
- Published
- 2017
- Full Text
- View/download PDF
47. Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.
- Author
-
Aveic S, Pantile M, Seydel A, Esposito MR, Zanon C, Li G, and Tonini GP
- Subjects
- Anaplastic Lymphoma Kinase, Blotting, Western, Cell Cycle drug effects, Cell Movement drug effects, Cell Proliferation drug effects, Fluorescent Antibody Technique, Humans, Immunoenzyme Techniques, Neuroblastoma drug therapy, Neuroblastoma metabolism, Phosphorylation drug effects, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction drug effects, Tumor Cells, Cultured, Wound Healing drug effects, Apoptosis drug effects, Autophagy drug effects, Benzamides pharmacology, Indazoles pharmacology, Neuroblastoma pathology, Receptor Protein-Tyrosine Kinases antagonists & inhibitors
- Abstract
Neuroblastoma (NB) is a threatening childhood malignancy. Its prognosis is affected by several morphological, and biological characteristics, including the constitutive expression of ALK tyrosine kinase. In this study we examined the therapeutic potential of a novel ALK inhibitor, entrectinib, in obliterating NB tumor cells. Entrectinib showed the growth-inhibitory effects on NB cells with a 50% inhibitory concentration range of 0.03-5 μM. In the ALK-dependent cells, entrectinib mediated G1-arrest, which was associated with modified expression of multiple cell-cycle regulators. Down-regulation of Ki-67, and attenuated phosphorylation of ERK1/2, and STAT3, correlated with observed antiproliferative capacity of entrectinib. Initial cytostatic activity of entrectinib was followed by concentration-dependent apoptotic cell death, and Caspase-3 activation. However, we delineated a reduced sensitivity of ALK mutated NB cells to entrectinib, and demonstrated strong activation of autophagy in SH-SY5YF1174L NB cell line. Abrogation of autophagy by chloroquine increased significantly the toxicity of entrectinib, as confirmed by enhanced death rate, and PARP protein cleavage in SH-SY5YF1174L cells. In aggregate, our data show that entrectinib inhibits proliferation, and induces G1-arrest, and apoptosis in NB cells. We propose entrectinib for further consideration in treatment of NB, and recommend pharmacological inhibition of autophagy to be explored for a combined therapeutic approach in NB patients that might develop resistance to entrectinib.
- Published
- 2016
- Full Text
- View/download PDF
48. Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group.
- Author
-
Mazzocco K, Defferrari R, Sementa AR, Garaventa A, Longo L, De Mariano M, Esposito MR, Negri F, Ircolò D, Viscardi E, Luksch R, D'Angelo P, Prete A, Castellano A, Massirio P, Erminio G, Gigliotti AR, Tonini GP, and Conte M
- Subjects
- Adolescent, Adult, Child, Cytogenetic Analysis, Female, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Italy, Male, Multiplex Polymerase Chain Reaction, Neuroblastoma pathology, Young Adult, Chromosome Aberrations, Neuroblastoma genetics
- Abstract
Background: Less than 5% of neuroblastomas (NB) occur in adolescents and young adults (AYA), in whom the disease has an indolent and fatal course., Procedure: We studied the genomic profile and histological characteristics of 34 NBs from AYA patients enrolled in the Italian Neuroblastoma Registry (INBR) between 1979 and 2009., Results: Disease was disseminated in 20 patients and localized in 14; 30/34 tumors were classified as NB and 4/34 as nodular ganglioneuroblastoma (nGNB). Segmental Chromosome Aberrations (SCAs) were observed in 29 tumors (85%) namely 1p imbalance (58%), 17q gain (52%), 9p loss (32%), 11q loss (30%), 1q gain (17%), 7q gain (17%), 2p gain (14%), 3p loss (14%), and 4p loss (7%). MYCN amplification and MYCN gain were detected in 3 (10%) and 2 cases (7%) respectively. An anaplastic lymphoma receptor tyrosine kinase (ALK) gene mutation study on the available cases from this cohort revealed 4/25 (16%) mutated cases. In parallel, alpha thalassaemia/mental retardation syndrome X linked (ATRX) gene mutations were also sought, a novel mutation being detected in 1/21 (4,7%) cases., Conclusion: This study confirmed the low incidence of MYCN amplification in AYA and recorded a high frequency of 17q gain and 9p and 11q loss independently from the stage of the disease. The presence of 1q gain, which identifies patients with particularly aggressive disease, relapse and poor survival, was also detected. Furthermore, the frequency of ALK mutations suggests that a target-based therapy with ALK inhibitors might be effective in this subset of patients., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
49. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.
- Author
-
Stigliani S, Scaruffi P, Lagazio C, Persico L, Carlini B, Varesio L, Morandi F, Morini M, Gigliotti AR, Esposito MR, Viscardi E, Cecinati V, Conte M, and Corrias MV
- Subjects
- Bone Marrow Neoplasms secondary, Cell Line, Tumor, Child, Child, Preschool, Female, Focal Adhesions physiology, Gene Expression Profiling, Humans, Infant, Male, Neuroblastoma pathology, Real-Time Polymerase Chain Reaction, Transcription Factors metabolism, Transfection, Bone Marrow Neoplasms genetics, Gene Expression Regulation physiology, MicroRNAs genetics, Neuroblastoma genetics
- Abstract
To get insights on the metastatic process of human neuroblastoma (NB), the miRNA expression profile of bone marrow (BM)-infiltrating cells has been determined and compared to that of primary tumors.Twenty-two BM-infiltrating cells, 22 primary tumors, and 4 paired samples from patients with metastatic NB aged > 12 months were analyzed for the expression of 670 miRNAs by stem-loop RT-qPCR. The miRNAs whose expression was significantly different were subjected to selection criteria, and 20 selected miRNAs were tested in 10 additional BM-infiltrating cells and primary tumors. Among the miRNAs confirmed to be differentially expressed, miR-659-3p was further analyzed. Transfection of miR-659-3p mimic and inhibitor demonstrated the specific suppression and over-expression, respectively, of the miR-659-3p target gene CNOT1, a regulator of transcription of genes containing AU-rich element (ARE) sequence. Among the ARE-containing genes, miR-659-3p mimic and inhibitor specifically modified the expression of AKT3, BCL2, CYR61 and THSB2, belonging to the focal adhesion pathway. Most importantly, in BM-infiltrating cells CNOT1 expression was significantly higher, and that of AKT3, BCL2, THSB2 and CYR61 was significantly lower than in primary tumors. Thus, our study suggests a role of the focal adhesion pathway, regulated by miR-659-3p through CNOT1, in the human NB metastatic process.
- Published
- 2015
- Full Text
- View/download PDF
50. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II.
- Author
-
Russo R, Langella C, Esposito MR, Gambale A, Vitiello F, Vallefuoco F, Ek T, Yang E, and Iolascon A
- Subjects
- Adult, Amino Acid Sequence, Base Sequence, Child, Exons, Female, Genotype, Humans, Introns, Male, Pedigree, Polymorphism, Genetic, RNA Splice Sites, Vesicular Transport Proteins metabolism, Anemia, Dyserythropoietic, Congenital genetics, Anemia, Dyserythropoietic, Congenital metabolism, Mutation, Phenotype, Vesicular Transport Proteins genetics
- Abstract
Congenital dyserythropoietic anemia type II, a recessive disorder of erythroid differentiation, is due to mutations in SEC23B, a component of the core trafficking machinery COPII. In no case homozygosity or compound heterozygosity for nonsense mutation(s) was found. This study represents the first description of molecular mechanisms underlying SEC23B hypomorphic genotypes by the analysis of five novel mutations. Our findings suggest that reduction of SEC23B gene expression is not associated with CDA II severe clinical presentation; conversely, the combination of a hypomorphic allele with one functionally altered results in more severe phenotypes. We propose a mechanism of compensation SEC23A-mediated which justifies these observations., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.